News

November 13, 2017November 13, 2017

Start-Up NIMo Wins SPARK Co-Lab 2017 Design Course Pitch Night

News

Medical device start-up NIMo has taken first place at the SPARK Co-Lab 2017 Design Course Pitch Night in Australia, for its wearable technology to self-manage chronic disease such as inflammatory bowel disease ... Read more

November 9, 2017

Cigarette Smoking Led to Colitis Through a T-cell Response in Mice

News

Researchers have found that cigarette smoking can induce colitis in mice through specific immune cell response. The study “Cigarette Smoking Triggers Colitis by IFN-γ+ CD4+ T Cells,” was published in ... Read more

November 8, 2017November 8, 2017

RedHill Offers Data Showing EnteraGam’s Benefits as Dietary Therapy for IBD Patients

News

RedHill Biopharma says its medical food, EnteraGam, is clinically and economically beneficial for inflammatory bowel disease (IBD) patients with chronic diarrhea. The Israeli company presented EnteraGam on Nov. 7 at the International Society ... Read more

November 7, 2017

Simponi Maintains Long-Term Effects in UC Patients, GO-COLITIS Results Show

News

Results from the GO-COLITIS clinical trial (NCT02092285) confirm that the long-term effects of Janssen Pharmaceutical’s Simponi (golimumab) were maintained in patients with ulcerative colitis (UC), according to MSD, sponsor of the study. The United Kingdom ... Read more

November 6, 2017November 6, 2017

Real-world Data Continues Showing Benefits of Takeda’s Entyvio for IBD Patients

News

Real-world data demonstrates the safety, tolerability, and efficacy of Entyvio (vedolizumab) in treating ulcerative colitis (UC) and Crohn’s disease, confirming previous data collected in clinical trials. These findings were the ... Read more

November 3, 2017November 3, 2017

Role of Genetics in IBD Development and Treatment Response Focus of Irish Study

News

Genomics Medicine Ireland (GMI) is launching a study to investigate the role genes may play in developing and treating inflammatory bowel disease (IBD), and how genetic risks might be affected by ... Read more

November 2, 2017November 2, 2017

Crohn’s & Colitis Foundation Receives $5 Million Donation to Fund IBD Research

News

The Crohn’s & Colitis Foundation has received $5 million from the Litwin family to fund research on inflammatory bowel disease (IBD). The grant, funded through Litwin IBD Pioneers, will finance studies on ... Read more

November 1, 2017

Effectiveness, Safety of Remicade’s Biosimilar, Inflectra, Confirmed in Phase 3 Trial

News

Switching Crohn’s disease patients from Remicade (infliximab) to its biosimilar Inflectra has no negative impact to treatment safety or effectiveness, a Phase 3 clinical trial shows. Pfizer and Celltrion Healthcare jointly presented those ... Read more

October 31, 2017

Enterome’s Investigational EB8018 for Crohn’s is Found Safe in Phase 1 Trial

News

Enterome Bioscience’s EB8018, a potential new therapy for Crohn’s disease, was well-tolerated by healthy volunteers in a Phase 1 clinical trial. EB8018 targets the gut microbiome (the gut includes the ... Read more

October 30, 2017October 30, 2017

Researchers Discover Link Between Vitamin A Metabolism and Harmful Gut Inflammation

News

Researchers at Case Western Reserve University School of Medicine in Cleveland, Ohio, have discovered a link between uncontrolled vitamin A metabolism and damaging inflammation in the gut. The discovery adds key details ... Read more